[Double-blind comparison of parsalmide and diazepam in anxious and depressive neurotic syndromes].

Abstract

Parsalmide- a new drug- is effective in the relief of inflammation and pain. In a double-blind, between-patients, cross-over trial with diazepam in 16 subjects with anxiety and depression, however, it proved less successful in relieving anxiety, though it was on a par with diazepam on an overall evaluation. The daytime somnolence and asthenia observed with diazepam were not observed with parsalmide.

• Authors: V Poli
• Journal: Minerva medica (Minerva Med) Vol. 67 Issue 52 Pg. 3413-7 (Oct 31 1976) ISSN: 0026-4806 [Print] Italy
• Vernacular Title: Confronto a "cecità doppia" tra parsalmide e diazepam nelle sindromi nevrotiche ansioso-depressive
• PMID: 11425 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, English Abstract, Journal Article)

Chemical References

• Anti-Anxiety Agents
• Anti-Inflammatory Agents, Non-Steroidal
• Benzamides
• Diazepam

Topics

• Adjustment Disorders (drug therapy)
• Adult
• Aged
• Anti-Anxiety Agents
• Anti-Inflammatory Agents, Non-Steroidal (adverse effects, therapeutic use)
• Anxiety Disorders (drug therapy)
• Benzamides (adverse effects, therapeutic use)
• Clinical Trials as Topic
• Diazepam (therapeutic use)
• Drug Evaluation
• Female
• Humans
• Male
• Middle Aged